Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

Cancer vaccine being created by UK scientists could stop disease up to 20 years early - A new partnership between the ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...